Brussels Partners With the American Vaccine Manufacturer
US biotechnology company Moderna has agreed with the European Commission to provide 80 million doses of a coronavirus vaccine when it becomes available.
It comes with an option for EU member states to purchase an additional 80 million doses besides. Moderna has announced this.
It is the committee’s fifth deal with manufacturers on the supply of vaccines if they prove useful and safe.
Brussels is in talks with several companies to increase the chance that Europeans will not miss out when an effective means become available.
Last week, the committee reached an agreement with the German pharmaceutical company CureVac for the delivery of 225 million doses.
Agreements in principle have already been made with AstraZeneca and Janssen Vaccines in Leiden, in both cases for 400 million doses, and with the pharmaceutical companies Sanofi and GlaxoSmithKline (GSK) for 300 million doses.